Vertex Pharmaceuticals INC / Ma (VRTX) — DEF 14A Filings
All DEF 14A filings from Vertex Pharmaceuticals INC / Ma. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Vertex Pharma DEF 14A: Executive Compensation Details
— Apr 3, 2025 Risk: low
Vertex Pharmaceuticals Inc. filed its DEF 14A on April 3, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, includi -
Vertex Pharmaceuticals Inc. files DEF 14A with executive compensation details
— Apr 4, 2024 Risk: low
VERTEX PHARMACEUTICALS INC / MA (VRTX) filed a Proxy Statement (DEF 14A) with the SEC on April 4, 2024. Vertex Pharmaceuticals Inc. filed a DEF 14A on April 4,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX